Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$6.5 - $8.91 $18,960 - $25,990
2,917 Added 22.27%
16,018 $124,000
Q1 2024

May 13, 2024

SELL
$5.37 - $8.35 $253,979 - $394,921
-47,296 Reduced 78.31%
13,101 $93,000
Q4 2023

Feb 12, 2024

BUY
$4.44 - $6.7 $45,345 - $68,427
10,213 Added 20.35%
60,397 $404,000
Q3 2023

Nov 02, 2023

BUY
$5.23 - $9.24 $94,187 - $166,403
18,009 Added 55.97%
50,184 $282,000
Q2 2023

Jul 25, 2023

BUY
$4.36 - $6.2 $60,019 - $85,349
13,766 Added 74.78%
32,175 $177,000
Q1 2023

May 11, 2023

BUY
$4.71 - $6.66 $86,706 - $122,603
18,409 New
18,409 $115,000
Q2 2022

Feb 01, 2023

BUY
$5.84 - $20.02 $26,934 - $92,332
4,612 Added 36.07%
17,397 $103,000
Q2 2022

Aug 08, 2022

BUY
$5.84 - $20.02 $26,934 - $92,332
4,612 Added 36.07%
17,397 $103,000
Q1 2022

Feb 01, 2023

BUY
$13.62 - $32.45 $174,131 - $414,873
12,785 New
12,785 $247,000
Q1 2022

May 10, 2022

BUY
$13.62 - $32.45 $174,131 - $414,873
12,785 New
12,785 $247,000

Others Institutions Holding GDRX

About GoodRx Holdings, Inc.


  • Ticker GDRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 84,394,800
  • Market Cap $375M
  • Description
  • GoodRx Holdings, Inc., through its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated pri...
More about GDRX
Track This Portfolio

Track Keebeck Alpha, LP Portfolio

Follow Keebeck Alpha, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Keebeck Alpha, LP, based on Form 13F filings with the SEC.

News

Stay updated on Keebeck Alpha, LP with notifications on news.